Abbott is the only company who manufactures these reagents that are for use on the Abbott Architect i1000 used in the Lab. There are no commercial substitutes. It is important to be consistent with the reagents being used in order remain in complaint with the Clinical Laboratory Improvement Amendment (CLIA) guidelines.
It is the understanding of the Government that an award to any other source would cause unacceptable delays in meeting the requirements of the Government. Interested parties who feel that they possess the capabilities to provide the services described above should submit a capability statement demonstrating their abilities to provide the services. The information received in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive requirement. Please send your documentation to Deborah Workman by fax (770) 488-2868, or email to [email protected]. Documentation should be received within fifteen (15) days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract, based upon responses to this notification, is solely within discretion of the government.